Literature DB >> 17010440

Inhibition of aldehyde detoxification in CNS mitochondria by fungicides.

Laura J Leiphon1, Matthew J Picklo.   

Abstract

Among the several converging factors leading to Parkinson's disease, epidemiological studies indicate a correlation between Parkinson's disease (PD) with living in a rural area and/or exposure to agricultural pesticides. In this present study, we examined the potential of multiple agricultural pesticides for their ability to inhibit the function of whole, respiring rat brain mitochondria using the oxidation of the neurotoxic lipid-aldehyde trans-4-hydroxy-2-nonenal (HNE) as a biomarker for mitochondrial aldehyde dehydrogenase (ALDH) activity in situ. We chose an arbitrary cutoff concentration of 10 microM of each pesticide. Our data demonstrate that only four of the eighteen compounds tested inhibited oxidation of HNE to trans-4-hydroxy-2-nonenoic acid (HNEAcid). These compounds included rotenone, maneb, mancozeb, and benomyl. Surprisingly, maneb, mancozeb, and benomyl did not inhibit mitochondrial respiration but inhibited the activity of purified rat ALDH2 and rat ALDH5A, enzymes found in brain mitochondria that oxidize HNE and aldehydes derived from neurotransmitters. Our data demonstrate that mitochondrial ALDHs are sensitive targets of pesticide inactivation and that pesticides such as maneb and benomyl can decrease the detoxification of lipid peroxidation derived aldehydes such as HNE and, likely, aldehydes derived from neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010440     DOI: 10.1016/j.neuro.2006.08.008

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  14 in total

1.  NADH fluorescence lifetime analysis of the effect of magnesium ions on ALDH2.

Authors:  Thomas P Gonnella; Travis S Leedahl; Jordan P Karlstad; Matthew J Picklo
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

2.  Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.

Authors:  David S Goldstein; Patti Sullivan; Adele Cooney; Yunden Jinsmaa; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Neurochem       Date:  2015-02-25       Impact factor: 5.372

Review 3.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

Review 4.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

Review 5.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Authors:  Che-Hong Chen; Julio Cesar Batista Ferreira; Eric R Gross; Daria Mochly-Rosen
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

6.  Fluorescence lifetime analysis and effect of magnesium ions on binding of NADH to human aldehyde dehydrogenase 1.

Authors:  Thomas P Gonnella; Jennifer M Keating; Jessica A Kjemhus; Matthew J Picklo; Joseph P Biggane
Journal:  Chem Biol Interact       Date:  2013-01-04       Impact factor: 5.192

7.  Quercetin induces mitochondrial biogenesis in experimental traumatic brain injury via the PGC-1α signaling pathway.

Authors:  Xiang Li; Handong Wang; Yongyue Gao; Liwen Li; Chao Tang; Guodao Wen; Youqing Yang; Zong Zhuang; Mengliang Zhou; Lei Mao; Youwu Fan
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

8.  Relative inhibitory potency of molinate and metabolites with aldehyde dehydrogenase 2: implications for the mechanism of enzyme inhibition.

Authors:  Erin M G Allen; David G R Anderson; Virginia R Florang; May Khanna; Thomas D Hurley; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2010-10-18       Impact factor: 3.739

9.  Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl.

Authors:  Amy R Biermann; Deborah A Hogan
Journal:  mSphere       Date:  2022-04-27       Impact factor: 5.029

10.  Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.

Authors:  Arthur G Fitzmaurice; Shannon L Rhodes; Aaron Lulla; Niall P Murphy; Hoa A Lam; Kelley C O'Donnell; Lisa Barnhill; John E Casida; Myles Cockburn; Alvaro Sagasti; Mark C Stahl; Nigel T Maidment; Beate Ritz; Jeff M Bronstein
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.